Trials / Recruiting
RecruitingNCT04593082
Obesity and Pediatric Multiple Sclerosis
Obesity as a Driver of Inflammation and Brain Volume Loss in Pediatric Multiple Sclerosis.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 116 (estimated)
- Sponsor
- University of Virginia · Academic / Other
- Sex
- All
- Age
- 10 Years – 20 Years
- Healthy volunteers
- Accepted
Summary
Obesity is one possible contributor to severity of multiple sclerosis and progression of the disease. We already know that obesity is a risk determinant for acquiring MS, yet the impact of obesity on pediatric MS disease expression and course is unknown. This study will evaluate the relationship between obesity, obesity-derived inflammatory mediators, and imaging metrics of MS severity in children. Understanding how childhood obesity contributes to MS severity/progression may yield fundamental insights into disease pathobiology - which may thereby lead to effective strategies for halting its progression in its earliest stages.
Conditions
Timeline
- Start date
- 2021-06-03
- Primary completion
- 2025-06-01
- Completion
- 2025-06-01
- First posted
- 2020-10-19
- Last updated
- 2024-12-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04593082. Inclusion in this directory is not an endorsement.